SPC476
momelotinib, including momelotinib dihydrochloride monohydrate
Status:
UmsóknApplication date:
13.7.2024Application published:
15.8.2024
Max expiry date:
24.1.2039Medicine name:
OmjjaraMedicine for children:
No
Timeline
Today
13.7.2024Application
15.8.2024Publication
24.1.2039Expires
Marketing license
IS authorization number:
EU/1/23/1782Date:
21.2.2024
Foreign authorization number:
EU/1/23/1782Date:
25.1.2024
Owner
Name:
GLAXOSMITHKLINE LLCAddress:
251 Little Falls Drive, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128 Reykjavík
Patent
Number:
EP3154950